Evidence map›Paper›PMID 42475391›Full record

ArticlePLoS pathogens2026

Fibrillarin-mediated 2'-O-methylation serves as a translation brake on uncapped enterovirus RNA.

Kui Zhang, Xuliu Zhou, Baocheng Yu, Xiang Guo, Li Zuo, Lishi Liu, Zhen Chen, Xueyan Zhang, Haojie Hao, Huanzhou Xu and 3 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kui ZhangCenter for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Xuliu ZhouCenter for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Baocheng YuCenter for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Xiang GuoCenter for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Li ZuoCenter for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Lishi LiuCenter for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Zhen ChenCenter for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Xueyan ZhangCenter for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Haojie HaoCenter for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Huanzhou XuCenter for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Fang HuangHubei Jiangxia Laboratory, Wuhan, Hubei, China.
Wuxiang GuanCenter for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.
Haibin LiuCenter for Emerging Infectious Diseases, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China.ORCID 0000-0003-3601-6066

Funding

National Key R&D Program of ChinaNational Natural Science Foundation of ChinaNatural Science Foundation of WuhanStrategic Priority Research Program of the Chinese Academy of Sciences
6 · The paper itself

Abstract

2'-O-methylation (Nm) is a key epitranscriptomic mark across diverse RNAs, yet its role in antiviral defense remains largely unexplored. To systematically investigate the landscape and functional significance of internal Nm modifications on enterovirus RNAs, a sensitive sequencing method termed RACE-Nm was established, in combination with the machine learning-based predictor NanoNm, to map Nm sites on low-abundance RNAs at single-nucleotide resolution. A conserved Nm site was identified at nucleotide 307C within the viral internal ribosome entry site (IRES), which was catalyzed by the methyltransferase FBL. The 2'-O-methylation at 307C caused steric hindrance that disrupted PCBP2 recruitment to the IRES and repressed cap-independent translation. Consequently, FBL-mediated suppression of IRES activity limited the production of the viral RNA polymerase 3D, which in turn prevented the upregulation of a set of pro-viral host genes, including FOSL1, ITGB3, and KCNQ4. The physiological importance of this defense mechanism was further demonstrated in vivo, as EV71 mutant lacking the 307C site showed markedly enhanced replication, aggravated tissue damage, and increased lethality in mouse model. Our study establishes FBL-mediated internal Nm modification as a novel host defense pathway that directly targets cap-independent translation to restrict enteroviral infection, highlighting the epitranscriptomic regulation of host-virus interactions.

Indexed as

Enterovirus A, HumanEnterovirus InfectionsProtein BiosynthesisRNA, ViralAnimalsChromosomal Proteins, Non-HistoneEpitranscriptomeHumansInternal Ribosome Entry SitesMethylationMiceRNA-Binding ProteinsRNA MethylationVirus ReplicationChromosomal Proteins, Non-HistonefibrillarinInternal Ribosome Entry SitesRNA-Binding ProteinsRNA, Viral

Identifiers

PMID42475391
PMCPMC13405287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.